Clinical Trial Update: A Comparison of Technegas and Xenon-133 Planar Lung Imaging in Subjects Referred for Ventilation Scintigraphy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Technegas vs Xenon-133 planar imaging in ventilation scintigraphy for lung structure assessment was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Structure Disorders

Drugs mentioned

• Technegas (Kit for the preparation of technetium Tc-99m-labeled carbon inhalation aerosol)
• Xenon-133 (Xenon-133)

Snippet

Sponsor: Cyclomedica Australia PTY Limited | Conditions: Lung Structure Determination | Phase 3 | Status: TERMINATED | Results posted: 2021-09-24